Telix Pharmaceuticals Stock Number Of Employees
| TLX Stock | 30.33 0.21 0.70% |
Telix Pharmaceuticals fundamentals help investors to digest information that contributes to Telix Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Telix Stock. The fundamental analysis module provides a way to measure Telix Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Telix Pharmaceuticals stock.
Telix |
Telix Pharmaceuticals Company Number Of Employees Analysis
Telix Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Telix Pharmaceuticals Number Of Employees | 27 |
Most of Telix Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Telix Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Telix Pharmaceuticals is currently employing 27.0 people. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of employees for all Australia stocks is notably lower than that of the firm.
Telix Pharmaceuticals is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,827. Telix Pharmaceuticals claims roughly 27.0 in number of employees contributing just under 2% to equities under Health Care industry.Telix Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0536 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 10.08 B | ||||
| Shares Outstanding | 334.72 M | ||||
| Shares Owned By Insiders | 41.16 % | ||||
| Shares Owned By Institutions | 17.14 % | ||||
| Price To Book | 20.67 X | ||||
| Price To Sales | 12.87 X | ||||
| Revenue | 496.66 M | ||||
| Gross Profit | 509.68 M | ||||
| EBITDA | 22.97 M | ||||
| Net Income | 5.21 M | ||||
| Total Debt | 17.45 M | ||||
| Book Value Per Share | 1.70 X | ||||
| Cash Flow From Operations | 23.88 M | ||||
| Earnings Per Share | 0.18 X | ||||
| Target Price | 29.73 | ||||
| Number Of Employees | 27 | ||||
| Beta | 2.41 | ||||
| Market Capitalization | 10.08 B | ||||
| Total Asset | 398.3 M | ||||
| Retained Earnings | (263.67 M) | ||||
| Working Capital | 67.44 M | ||||
| Net Asset | 398.3 M |
About Telix Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Telix Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telix Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telix Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.